Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer

Tertiary lymphoid structures (TLS) existence is correlated with favorable prognosis in many types of cancer including non-small cell lung cancer (NSCLC). However, TLS formation and its relationship with treatment response remains unknown in NSCLC who received anti-PD-1 antibody plus chemotherapy as...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaoyan, Liu, Weiran, Sun, Leina, Mo, Huilan, Feng, Yingnan, Wu, Xinyi, Li, Chenguang, Chen, Chen, Li, Jingjing, Xin, Ying, Zhang, Zhenfa, Wang, Changli, Zhang, Bin, Yue, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644367/
https://www.ncbi.nlm.nih.gov/pubmed/37011953
http://dx.doi.org/10.1136/jitc-2022-005531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644367/
https://www.ncbi.nlm.nih.gov/pubmed/37011953
http://dx.doi.org/10.1136/jitc-2022-005531

Ejemplares similares